Tamocare 20 Tablet: Tamoxifen 20 mg - The Cornerstone of Endocrine Therapy

Mechanism of Action: Selective Estrogen Receptor Modulation (SERM) in ER+Cancer

Key Application: 5-10 Years of Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

Prophylactic Use: Approved for Breast Cancer Risk Reduction in High-Risk Women

Ensuring Compliance and Safety in Prolonged Oral Oncology Treatment
Secure Your Monopoly: Tamocare 20 PCD Pharma Franchise in High-Volume Chronic Oncology Care

Home/Products /tamoxifen-20mg-tablet

Tamotreat 20 Tablet

Composition : Tamoxifen 20mg Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Tamotreat 20 Tablet (Tamoxifen ) is an established and indispensable oral medication in oncology, classified as a Selective Estrogen Receptor Modulator (). It is the cornerstone of endocrine therapy for patients with Hormone Receptor-Positive (/) breast cancer.

Mechanism and Impact:Tamoxifen primarily works by binding to estrogen receptors on breast cancer cells, acting as an anti-estrogen, thereby blocking estrogen's proliferative effects. This crucial mechanism makes it highly effective in reducing the risk of recurrence and mortality in patients following primary treatment. It is typically prescribed for long-term use, lasting 5 to 10 years.

Key Therapeutic Uses:

  • Adjuvant Therapy: Reducing recurrence and improving overall survival in patients with early-stage .

  • Metastatic Disease: Treatment of advanced or metastatic .

  • Risk Reduction: Approved for reducing breast cancer incidence in high-risk women.

Due to the essential nature and the prescribed - year duration of treatment, Tamoxifen guarantees exceptionally high, stable, and long-term prescription volume. We offer an exclusive PCD Pharma Franchise opportunity for Tamocare 20 Tablet, enabling partners to dominate the foundational segment of the market.

Read More

About the Product

Tamotreat 20 Tablet (Tamoxifen ) is an established and indispensable oral medication in oncology, classified as a Selective Estrogen Receptor Modulator (). It is the cornerstone of endocrine therapy for patients with Hormone Receptor-Positive (/) breast cancer.

Mechanism and Impact:Tamoxifen primarily works by binding to estrogen receptors on breast cancer cells, acting as an anti-estrogen, thereby blocking estrogen's proliferative effects. This crucial mechanism makes it highly effective in reducing the risk of recurrence and mortality in patients following primary treatment. It is typically prescribed for long-term use, lasting 5 to 10 years.

Key Therapeutic Uses:

  • Adjuvant Therapy: Reducing recurrence and improving overall survival in patients with early-stage .

  • Metastatic Disease: Treatment of advanced or metastatic .

  • Risk Reduction: Approved for reducing breast cancer incidence in high-risk women.

Due to the essential nature and the prescribed - year duration of treatment, Tamoxifen guarantees exceptionally high, stable, and long-term prescription volume. We offer an exclusive PCD Pharma Franchise opportunity for Tamocare 20 Tablet, enabling partners to dominate the foundational segment of the market.

Possible side effects include stomach upset, nausea, dizziness, or diarrhea. Rarely, allergic reactions or gastrointestinal bleeding may occur.

Tamotreat 20 Tablet is indicated for the relief of mild to moderate pain and inflammation, including headaches, menstrual pain, and musculoskeletal pain.

Use this medication as prescribed by your doctor. Avoid exceeding the recommended dosage. Inform your doctor of any existing medical conditions or ongoing medications.

Store the suspension in a cool, dry place, away from direct sunlight. Shake well before use. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation